Cannabis & CMT Webinar

by | Mar 25, 2024 | 0 comments

Angie Roullier is the author of “Pot for the People: The plant, the people, and the shop policies of cannabis” – Cannabis Tutor/Patient Relations

“Over 12 years ago, I chose to give cannabis a shot as a method of treatment for my CMT. Not only did I find that it greatly improved my quality of life, but I was now wildly curious about how it worked and how it could help others. Having run through the gauntlet of cannabis retail positions and tutoring within the Detroit Metro area, I have crossed paths with thousands of people looking to cannabis for help with their medical conditions.

I have seen cannabis do wonders for so many of these people, and I have seen it do absolutely nothing for others. Cannabis is not for everyone. Cannabis is not a cure-all, a magic bullet, or the last medicine you’ll ever take. But what it may have is the potential to help. Naturally.”

Agenda:

  • About Angie & her work
  • What do CMTers need to know before they try Cannabis for their symptoms?
  • What are the different types and methods of consumption?
  • What are the benefits and risks?
  • Where to purchase?
  • Q&A

Learn more on this topic

Related Blog Posts

HNF is Reshaping Drug Repurposing for CMT

HNF is Reshaping Drug Repurposing for CMT

HNF has partnered with Rarebase, a public benefit precision medicine company that has screened a large library of FDA approved small molecules to identify candidates for various types of CMT. Their tech-enabled drug discovery platform is called Function™. There are many published discoveries on the genetic cause of many types of CMT, including an understanding of the basic mechanism of disease and potential targets for FDA-approved drug repurposing. It is this understanding that allows HNF and Rarebase to target the genetic root cause of CMT.

Join the conversation

Leave a Comment

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news